Lincoln Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA93105
EBIT8597
Earning Per Share3134
Expenses337377
Net Profit6269
Net Profit Margin1515
Operating Profit Margin2222
Profit Before Tax8496
Dividends Per Share22
Operation Revenue430482

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Lincoln Pharma is 105 as of 3/2/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities2753756939
Investing Activities-12-18-31-64-37
Financing Activities-11-36-38-6-5
Others00000
Net Cash Flow3-17-1-2

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Lincoln Pharma is 39 as of 3/2/2024